ConductScience.org, home

Paper36920988

Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis.

Yin S and 4 others. PLoS Med, 2023. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis. Papers, record 36920988. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36920988

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis.
PubMed
Journal
PLoS Med
PubMed
Year
2023
PubMed
Publication types
Meta-Analysis, Systematic Review, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
1.99
iCite
Revised in PubMed
2023-04-07
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yin SSaifuhttps://orcid.org/0000-0001-9710-7872
2Zhang FFan
3Wu JJiapei
4Lin TTaohttps://orcid.org/0000-0003-2166-2217
5Wang XXianding

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Organ TransplantationMajor topic
Humans
Hepatitis B virus
Rituximab
Retrospective Studies
Incidence
Antiviral Agents
Risk Factors
Hepatitis B Antibodies

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129621059
Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation.
Transplantation2018https://conductscience.org/library/papers/29621059PubMed
215653420HBV reactivation after kidney transplantation.J Clin Virol2005https://conductscience.org/library/papers/15653420PubMed
325707744Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.Am J Transplant2015https://conductscience.org/library/papers/25707744PubMed
432057171Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients.J Viral Hepat2020https://conductscience.org/library/papers/32057171PubMed
525363471Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression.Transpl Int2015https://conductscience.org/library/papers/25363471PubMed
619622551Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.BMJ2009https://conductscience.org/library/papers/19622551PubMed
719072749Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells.Stat Med2009https://conductscience.org/library/papers/19072749PubMed
820827667Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data.Stat Med2010https://conductscience.org/library/papers/20827667PubMed
922436845EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.J Hepatol2012https://conductscience.org/library/papers/22436845PubMed
1032118794Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients.Medicine (Baltimore)2020https://conductscience.org/library/papers/32118794PubMed
113802833Meta-analysis in clinical trials.Control Clin Trials1986https://conductscience.org/library/papers/3802833PubMed
1232301874KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.Transplantation2020https://conductscience.org/library/papers/32301874PubMed
1328371939Rituximab and hepatitis B reactivation in HBsAg-negative/anti-HBc-positive kidney transplant recipients.Nephrol Dial Transplant2017https://conductscience.org/library/papers/28371939PubMed
1430295412Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients.Transpl Infect Dis2019https://conductscience.org/library/papers/30295412PubMed
1528856548Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis.Hepatol Int2017https://conductscience.org/library/papers/28856548PubMed
1623726628Clinical and virologic courses of hepatitis B surface antigen-negative and hepatitis B core or hepatitis B surface antibody-positive renal transplant recipients.Transplant Proc2013https://conductscience.org/library/papers/23726628PubMed
1725154638
Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
Transpl Infect Dis2014https://conductscience.org/library/papers/25154638PubMed
1828128861Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis.Hepatology2017https://conductscience.org/library/papers/28128861PubMed
1922921412Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection.J Clin Virol2012https://conductscience.org/library/papers/22921412PubMed
2034427860APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.Hepatol Int2021https://conductscience.org/library/papers/34427860PubMed

See all 35 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42953154Risk factors for postpartum alanine aminotransferase elevation in women with chronic hepatitis B infection: a systematic review and meta-analysis.Front Public Health2026https://conductscience.org/library/papers/42953154PubMed
42609305Epidemiologic and clinical characteristics of Mycobacterium tuberculosis infection in Guangxi, China, 2018-2023: a retrospective study.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42609305PubMed
42590149
Long-Term Clinical Outcomes of Kidney Transplantation from Hepatitis B Surface Antigen (HBsAg)-Positive Donors to HBsAg-Negative Recipients: A Systematic Review and Meta-Analysis of Real-World Studies.
J Clin Med2026https://conductscience.org/library/papers/42590149PubMed
42281419KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).Clin Mol Hepatol2026https://conductscience.org/library/papers/42281419PubMed
42005560Hepatitis B, C, and E viruses in solid organ transplantation: donor and recipient perspectives.JHLT Open2026https://conductscience.org/library/papers/42005560PubMed
41183666Antineoplastic agents-associated hepatitis B virus reactivation: Research progress and molecular mechanisms.Virus Res2025https://conductscience.org/library/papers/41183666PubMed
40753237Synchronous triple-negative breast cancer, rectal adenocarcinoma, and chemotherapy-induced hepatitis B virus reactivation: a case report and review of the literature.J Med Case Rep2025https://conductscience.org/library/papers/40753237PubMed
40143316HBV Reactivation in Immunosuppressed Patients: Screening, Prevention, and Management Including Solid Organ Transplant Recipients.Viruses2025https://conductscience.org/library/papers/40143316PubMed
39066442Hepatitis B Reactivation and Vaccination Effectiveness after Solid Organ Transplantation: A Matched Case-Control Study.Vaccines (Basel)2024https://conductscience.org/library/papers/39066442PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36920988

GET https://conductscience.org/api/papers/v1/36920988/references?page=2